Elsevier

Placenta

Volume 25, Supplement, April 2004, Pages S60-S71
Placenta

Maternal Adaptation to High-altitude Pregnancy: An Experiment of Nature—A Review

https://doi.org/10.1016/j.placenta.2004.01.008Get rights and content

Abstract

A long and productive history of studies at high altitude has demonstrated that chronic hypoxia plays a key role in the aetiology of intrauterine growth restriction (IUGR) and pre-eclampsia. Susceptibility to altitude-associated IUGR varies among high-altitude populations in relation to their duration of altitude exposure, with multigenerational residents demonstrating one-third the birth weight fall present in shorter-resident groups. Higher uteroplacental blood flow during pregnancy in multigenerational high-altitude residents suggests that such population differences are due, at least in part, to differences in maternal vascular responses to pregnancy. We hypothesize that natural selection acting on hypoxia-inducible factor (HIF)-targeted or -regulatory genes has enabled maternal vascular adaptation to pregnancy in long-resident high-altitude groups. Preliminary evidence in support of this hypothesis demonstrates that the potent HIF-targeted vasoconstrictor, endothelin-1 (ET-1), is differentially regulated by pregnancy and chronic hypoxia in Andean vs European residents of high altitude. Andeans show the normal, pregnancy-associated fall in ET-1 levels previously reported at low altitude, whereas Europeans have higher ET-1 levels and little pregnancy-associated change, like pre-eclamptic women. Single nucleotide polymorphisms (SNPs) in the ET-1 gene also differ in Andeans compared with low-altitude populations. We conclude that high altitude serves as an experiment of nature for elucidating genetic factors underlying susceptibility to complications of pregnancy and fetal life. Such studies may be important for identifying persons at risk for these complications at any altitude.

Introduction

Hypoxia is a frequent complication of prenatal life. When prolonged, it is associated with intrauterine growth restriction (IUGR) (Table 1) and increased perinatal mortality and morbidity. Whereas persons are subject to chronic hypoxia in utero at all elevations, the largest single group of persons at risk is the 140 million worldwide residents of high altitude(>2500 m or 8000 ft) [1]. There has been a long and productive history of studies of pregnancy, fetal and neonatal life at high altitude. The initial observations on a population level that fetal growth restriction and preterm delivery were separable causes of low birth weight were made there nearly 50 years ago ([2]reviewed in [3]). Not only was this crucial in terms of our current understanding of the causes of low birth weight but was followed by continued investigations demonstrating the utility of charting newborn birth weight in relation to gestational age as a predictor of infant mortality [4]. This system continues to be used worldwide; its introduction constitutes one of the truly great public health advances of our time. The first recognition that chronic hypoxia was part of the aetiology of pre-eclampsia was also made at high altitude [5]. Continuing investigations by several investigative groups [6], [7], [8], [9]are rapidly expanding our knowledge of the cellular and molecular mechanisms by which hypoxia influences the maternal, placental and fetal responses required to successfully produce the next generation.

Here we begin with a brief review of the magnitude and cause of the altitude-associated increase in IUGR. Because studies have been conducted at a range of elevations on three continents (North America, South America, Asia), we ask whether the decline in infant birth weight varies among populations and if so, what mechanisms are likely involved. We then move to a consideration of the physiological factors controlling uteroplacental blood flow since altered uteroplacental blood flow is a core predictor of pregnancy abnormalities [10]. After reviewing recent research addressing the effects of chronic hypoxia on uteroplacental blood flow, we ask whether these effects vary among populations or species in relation to the altitude-associated increase in IUGR. Finally, we consider the role that genetic factors may play in the population and species differences observed in altitude-associated IUGR, hypothesizing that variation in hypoxia-sensitive genes might be involved. We review the role played by the hypoxia-inducible factor (HIF) pathway since it is responsible for regulating most of the oxygen-sensitive genes. After surveying the HIF-regulated and regulatory genes differentially affected by pregnancy and chronic hypoxia, we consider the possibility that such genes may have been acted upon by natural selection in populations long resident at high altitude. We conclude with some future directions for research aimed at advancing our understanding of the genetic mechanisms regulating maternal physiological responses to human pregnancy.

Section snippets

Magnitude and cause of the birth weight decline

In Colorado and elsewhere, infant birth weight declines with increasing altitude, averaging a 100 g fall per 1000 m altitude gain (nearly a quarter of a pound per 3000 ft) [11], [12]. While convenient to express in this fashion, the decline in birth weight is actually curvilinear with the ‘breakpoint’ occurring about 2000 m or 6600 ft [13], consistent with the shape of the haemoglobin-oxygen dissociation curve. The entire distribution of birth weights is shifted to lower values, rather than

Normoxic pregnancy

Pregnancy affects all the determinants of O2delivery to the uteroplacental circulation. Ventilation rises, although this does not normally change arterial O2saturation since values are already nearly maximal. Haemoglobin declines due to greater plasma than red cell mass expansion and reduces arterial O2content. Thus a rise in blood flow is entirely responsible for increasing O2delivery to the uteroplacental circulation.

The rise in uteroplacental blood flow is due, in turn, to higher cardiac

Do genetic factors influence maternal vascular adaptation to pregnancy?

Population and species differences in the magnitude of hypoxia-associated IUGR suggest the involvement of genetic factors. Such genetic involvement is consistent with other studies suggesting associations between specific genetic variants and pre-eclampsia or IUGR [80], [81], [82], [83], [84], [85]. In evaluating the kinds of genetic factors that might be involved, we (and others) have been struck by the observation that many of the candidate genes thus far identified are part of the HIF

Genomic approaches for identifying candidate genes

Genomic approaches have been infrequently applied to pregnancy complications but offer considerable power for determining interindividual variation in risk factors for complex diseases [91], [92]. Such approaches include ones which take advantage of the possibility that natural selection has acted to differentiate one population, in this case Andeans, from other groups with shorter duration of high-altitude exposure with respect to genes influencing uteroplacental blood flow and fetal growth.

Directions for future study

Thus, the available data suggest that UA blood flow is lower during pregnancy at high altitude in settings where IUGR is most pronounced. Further the variation in hypoxia-associated IUGR that is evident both within as well as between species suggests important avenues for future studies designed to address the contribution of genetic factors to maternal vascular adaptation to pregnancy. Future studies are required for assaying additional SNPs near the candidate, HIF-targeted genes to verify the

Acknowledgments

Our appreciation is extended to the many subjects who have participated in our studies of pregnancy at high altitudes in Colorado, Peru, Tibet and Bolivia and to the technical staff at the Women's Health and Colorado High-Altitude Research Centers, the Bolivian High-Altitude Biology Institute, the Pennsylvania Department of Anthropology and the other sites which have cooperated with us in the past. We especially thank Ms Wendy MacCannell for her help with the preparation of this article and

References (142)

  • N.A. Kametas et al.

    Flow-mediated dilatation of the brachial artery in pregnancy at high altitude

    Br J Obstet Gynaecol

    (2002)
  • L.G. Thaete et al.

    Endothelin receptor A antagonism prevents hypoxia-induced intrauterine growth restriction in the rat

    Am J Obstet Gynecol

    (1997)
  • K.R. Kublickiene et al.

    Preeclampsia: evidence for impaired shear stress-mediated nitiric oxide release in uterine circulation

    Am J Obstet Gynecol

    (2000)
  • L.C. Rockwell et al.

    Chronic hypoxia diminishes pregnancy-associated DNA synthesis in guinea pig uteroplacental arteries

    Placenta

    (2000)
  • L. Zhang et al.

    Long-term high-altitude hypoxia increases plasma nitrate levels in pregnant ewes and their fetuses

    Am J Obstet Gynecol

    (1998)
  • D. Xiao et al.

    Endothelial nitric oxide release in isolated perfused ovine uterine arteries: effect of pregnancy

    Eur J Pharmacol

    (1999)
  • J. Huang et al.

    Sequence determinants in hypoxia-inducible factor-1alpha for hydroxylation by the prolyl hydroxylases PHD1, PHD2, and PHD3

    J Biol Chem

    (2002)
  • C. Schlotterer

    Hitchhiking mapping—functional genomics from the population genetics perspective

    Trends Genet

    (2003)
  • M.T. Hamblin et al.

    Complex signatures of natural selection at the Duffy blood group locus

    Am J Hum Genet

    (2002)
  • S. Niermeyer et al.

    The people

  • J.L. Lichty et al.

    Studies of babies born at high altitude

    Am J Dis Child

    (1957)
  • L.G. Moore

    Small babies and big mountains: John Lichty solves a Colorado mystery in Leadville

  • L.O. Lubchenco

    Intrauterine growth as estimated from liveborn birth-weight data at 24 to 42 weeks of gestation

    Pediatrics

    (1963)
  • P. Kaufmann et al.

    Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia

    Biol Reprod

    (2003)
  • G.M. Jensen et al.

    The effect of high altitude and other risk factors on birthweight: independent or interactive effects?

    Am J Public Health

    (1997)
  • D.A. Giussani et al.

    Effects of altitude versus economic status on birth weight and body shape at birth

    Pediatr Res

    (2001)
  • C. Unger et al.

    Altitude, low birth weight, and infant mortality in Colorado

    J Am Med Assoc

    (1988)
  • E. Krampl et al.

    Fetal biometry at 4300 m compared to sea level in Peru

    Ultrasound Obstet Gynecol

    (2000)
  • L.E. Keyes et al.

    Intrauterine growth restriction, preeclampsia and intrauterine mortality at high altitude in Bolivia

    Pediatr Res

    (2003)
  • S. Niermeyer

    Cardiopulmonary transition in the high altitude neonate

    High Alt Med Biol

    (2003)
  • R.E. McCullough et al.

    Fetal growth retardation and increased infant mortality at high altitude

    Arch Environ Health

    (1977)
  • Health conditions in the Americas. Scientific publication No. 549

    (1994)
  • A.S. Wiley

    Neonatal size and infant mortality at high altitude in the western Himalaya

    Am J Phys Anthropol

    (1994)
  • R.o. Bolivia

    Encuesta Nacional de Demografı́a y Salud

    (1998)
  • D. Giussani

    High altitude and rural living are associated with increased infant mortality in Bolivia

    J Soc Gynecol Investig

    (2002)
  • Epidemiol Bull

    (1999)
  • J.D. Haas

    Human adaptability approach to nutritional assessment: a Bolivian example

    Fed Proc

    (1981)
  • L.G. Moore

    Human genetic adaptation to high altitude

    High Alt Med Biol

    (2001)
  • L.G. Moore et al.

    Tibetan protection from intrauterine growth restriction (IUGR) and reproductive loss at high altitude

    Am J Human Biol

    (2001)
  • R.S. Weinstein et al.

    Early stress and later reproductive performance under conditions of malutrition and high altitude hypoxia

    Med Anthropol

    (1977)
  • L.G. Moore et al.

    Infant birth weight is related to maternal arterial oxygenation at high altitude

    J Appl Physiol

    (1982)
  • R. Chakraborty et al.

    Ethnicity determination by names among the Aymara of Chile and Bolivia

    Hum Biol

    (1989)
  • L.G. Moore et al.

    Andean compared with European babies are protected from altitude-associated intrauterine growth restriction (IUGR)

    High Alt Med Biol

    (2002)
  • M.A. Cadnapaphornchai et al.

    Chronic NOS inhibition reverses systemic vasodilation and glomerular hyperfiltration in pregnancy

    Am J Physiol Renal Physiol

    (2001)
  • N. Furuhashi et al.

    Maternal plasma endothelin levels and fetal status in normal and preeclamptic pregnancies

    Gynecol Obstet Invest

    (1995)
  • A. Luttun et al.

    Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered?

    J Clin Invest

    (2003)
  • S.E. Maynard et al.

    Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

    J Clin Invest

    (2003)
  • S.K. Palmer et al.

    Quantitative estimation of human uterine artery blood flow and pelvic blood flow redistribution in pregnancy

    Obstet Gynecol

    (1992)
  • W. Moll et al.

    The blood pressure in arteries entering the placentae of guinea pigs, rats, rabbits, and sheep

    Pflugers Arch

    (1973)
  • M. Stock et al.

    Maternal physiology during gestation

  • Cited by (0)

    View full text